Introduction
If any gene can claim to represent the concept itself of tumor suppression, this is RB (RB1), the gene whose loss-of-function is responsible for the susceptibility to retinoblastoma, a sporadic or hereditary pediatric tumor arising from retinal cells harboring either deletion or mutational inactivation of both RB alleles (Knudson, 1971; Knudson, 1986) . Indeed, RB mutations or deletions are shared by several tumor types and, in addition, exogenous expression of wild-type RB in RBdefective cancer cells reverts main characteristics of the neoplastic phenotype ( (Weinberg, 1995; Paggi et al., 1996; Bartek et al., 1997; Kaelin, 1999) 
and references therein).
RB is the founder of the RB family of genes and proteins, since two other factors structurally and functionally related, namely p107 (RBL1) (Ewen et al., 1991; Zhu et al., 1993) and Rb2/p130 (RBL2) (Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993) , have been subsequently identified. The RB family proteins share a considerable structural homology, primarily at the level of the 'pocket' domain, a complex structure subdivided in A-domain, spacer and B-domain. A-and B-domains are the most conserved among the three RB proteins and are involved in common functional characteristics (Paggi et al., 1996; Mulligan and Jacks, 1998) , the most relevant one being the ability to control the cell cycle by negative modulation of the transition between the G1 and S phases (Goodrich et al., 1991; Zhu et al., 1993; Claudio et al., 1994; Starostik et al., 1996) . To perform this task, these 'pocket proteins' utilize mechanisms mostly related to inactivation of transcription factors (Kouzarides, 1995) , such as those of the E2F family (Cao et al., 1992; Helin et al., 1992 Helin et al., , 1993 Shirodkar et al., 1992; Beijersbergen et al., 1994; Hijmans et al., 1995; Sardet et al., 1995; Hurford et al., 1997) , that promote the cell entrance into the S phase (Ewen, 1994; Weinberg, 1995; Paggi et al., 1996; Mulligan and Jacks, 1998) . Indeed, in addition to the cell cycle, the RB family proteins regulate a wide spectrum of complex biological phenomena, as differentiation, embryonic development, apoptosis and senescence ( (Riley et al., 1994; Sidle et al., 1996; Herwig and Strauss, 1997; Stiegler et al., 1998; Thomas et al., 2003; Liu et al., 2004; Kapic et al., 2006) and references therein). However, as mentioned above, the crucial function attributed to RB is its tumor suppressor capability, and some debates are still ongoing whether p107 or Rb2/p130 share with RB this key feature (Mulligan and Jacks, 1998; Classon and Dyson, 2001 ; Paggi and Giordano, 2001 ).
In 1971, the existence of the RB gene was initially postulated on the basis of the incidence of retinoblastoma in children (Knudson, 1971) , and in 1986, its cDNA was cloned (Friend et al., 1986) and, almost independently, other investigators recognized a set of cellular factors initially identified for their ability to physically interact with the Adenovirus 5 E1A oncoprotein. Indeed, major bands representing these proteins were named after their apparent SDS-PAGE molecular mass (Harlow et al., 1986) , that is, p60, p105, p107, p130 and p300. The subsequent characterization of these proteins first identified p105 as the product of the RB gene (Whyte et al., 1988) , and then p60 as cyclin A (Giordano et al., 1989; Pines and Hunter, 1990) . Later, genes encoding p107 (Ewen et al., 1991; Zhu et al., 1993) and pRb2/p130 (Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993) were cloned using different strategies. Finally p300, together with CBP, defines a family of transcriptional adaptor proteins that are specifically targeted by the E1A oncoprotein (Arany et al., 1995) .
Adenovirus E1A has been the most widely investigated small DNA tumor virus oncoprotein, but increasing interest is raised by the E1A-related E7 protein from transforming HPV strains, a major effector of HPV oncogenicity in humans (Gage et al., 1990; zur Hausen, 1996; Zwerschke and Jansen-Durr, 2000) . Recently, substantial attention has been given also to Polyomavirus oncoproteins, particularly large and small T antigens from Simian virus 40 (SV40), JC virus (JCV) and BK virus (BKV) (Croul et al., 2003; Helt and Galloway, 2003) , owing to their expression in some specific human tumors, as pleural mesothelioma or tumors of the central nervous system (CNS).
Mainly because of such findings, in the last two decades the 'viral hypothesis' of cancer has been strongly supported by the notion that a number of small DNA virus proteins, subsequently called as 'oncoproteins', play a key role in modulating crucial cellular regulatory processes, such as gene expression, cell cycle regulation, differentiation and apoptosis (Lavia et al., 2003) . Owing to these features, viral oncoproteins have been widely employed in several laboratories as cutting edge experimental tools to identify key families of regulators, particularly of cell cycle homeostasis (Ali and DeCaprio, 2001; Munger et al., 2001; Sang et al., 2002) .
Most of, if not all, the RB family proteins functions appear to be targeted by these small DNA virus oncoproteins. This review will focus on three classes of oncoproteins, namely Adenovirus E1A, Human papillomavirus (HPV) E7 and Polyomavirus large T antigen, which play a relevant role in cell transformation and consequently in cancer development.
Adenovirus early-region 1A
The early-region 1A (E1A) of the human adenovirus type 5 encodes for two major proteins of 243 and 289 residues (243R and 289R proteins), corresponding to the two major spliced RNA transcripts of 12S and 13S. Both transcripts share the same ATG and are constituted by two spliced exons. The first exon is 553 nucleotides long in the larger transcript and 415 in the shorter one, thus coding for 139 residues common to both 243R and 289R proteins and for an additional internal stretch of 46 amino acids unique to the 289R protein. The second exon is identical in the two proteins and encodes for the terminal 104 amino acids common to both proteins. Two regions highly conserved among the different adenoviral serotypes are comprised within the first 139 amino acids, namely conserved region 1 (CR1) (aa 41-72) and CR2 (aa 115-137) (Avvakumov et al., 2004) . These two conserved regions are crucial for the binding and inactivation of the RB family of pocket proteins.
In 1988, Whyte et al. identified pRb in a complex coimmunoprecipitating with E1A. Also, the other two members of the retinoblastoma family, p107 and pRb2/ p130, were first discovered through their association to E1A Herrmann et al., 1991) . Later, they were cloned and identified as pocket proteins (Ewen et al., 1991; Hannon et al., 1993; Li et al., 1993; Mayol et al., 1993; Zhu et al., 1993) .
Early-region 1A targets the B-domain (B-box) of the pocket domain of pRb, as most of the other viral proteins and cellular corepressors do. A characteristic feature of the proteins that target the retinoblastoma Bbox is the presence of a LxCxE sequence motif (Singh et al., 2005) . The LxCxE motif of the E1A proteins is found in the CR2 region (aa 122-126) (Figure 1) .
The tridimensional structure of the LxCxE-binding site of pRb has been determined in great detail, analysing the crystal structure of the RB pocket bound to a nine-residue peptide containing the LxCxE motif of HPV E7 (Lee et al., 1998) . The binding site structure consists in a shallow groove on the surface of the B-box region of the pocket, which accommodates the LxCxE peptide in an extended, b-strand conformation. The alternating Leu, Cys and Glu residues point towards the inner part of the groove, making contacts with specific non-contiguous pRb residues. These residues are extremely conserved between pRb and pRb-like proteins of different species (Ach et al., 1997; Lee et al., 1998; Lu and Horvitz, 1998) , indicating that this conserved groove of the B-box should play a critical role for the function of pRb, p107 and pRb2/p130.
The displacement of cellular proteins that interact with the conserved groove of pRb B-box by means of an LxCxE motif could be an important mechanism by which E1A interferes with the pocket protein functions. These cellular proteins include D-type Cyclins, HDAC-1 and BRG1 (Morris and Dyson, 2001) .
The E2F transcription factor family members do not possess the LxCxE motif, but share a specific 18-aa pRbbinding motif, close to their C-terminus (Helin et al., 1992; Shan et al., 1996) and belonging to their transactivation domain. The binding site for this motif is contained within the pRb pocket, but is distinct from the LxCxE binding groove (Lee et al., 1998; Kim et al., 2001) . Recent studies have determined the crystal structure of pRb A-B pocket bound to either the E2F (409-426) or the E2F-2 (410-427) peptide (Lee et al., 2002; Xiao et al., 2003) . As anticipated by genetic and structural considerations (Lee et al., 1998) , the boomerang-shaped E2F (409-426) peptide binds to a highly conserved groove on the surface of the central interface connecting the A and B boxes. The binding of pRb pocket masks several conserved residues of E2F peptides, critical for the E2F transacting activity. The E2F and the LxCxE-binding grooves are placed on the opposite faces of the pRb pocket.
E1A interacts with pRb also with its CR1 region, with an affinity 10 times lower than CR2 . While E1A CR1 and CR2 appear to bind independently to pRb, E1A CR1 interacts with the same region of the pRb pocket where E2F interacts, with approximately the same affinity . These facts suggest a two-step model for the disruption of E2F-pRb complexes by E1A. In the first step, the high affinity of E1A CR2 for the pRb pocket drives the initial interaction of E1A with E2F-pRb complexes, generating a ternary E1A-pRb-E2F complex and an increase of CR1 concentration in the proximity of the pRb-E2F contact site. Then, E1A CR1 will compete directly with E2F for binding pRb, causing its dissociation from the complex. Owing to the cumulative effect of CR1 and CR2, the affinity of E1A for pRb will be higher than that of E2F, thus driving the equilibrium towards the complete dissociation of E2F from pRb Ikeda and Nevins, 1993) .
As a consequence of the high conservation, between different species and among pocket protein members, shown by the structural features of pRb that interact with E1A CR1 and CR2, the other members of the pocket protein family p107 and pRb2/p130 interact in a similar way with E1A conserved regions (Lee et al., 1998; Lee et al., 2002; Xiao et al., 2003) .
The interaction of E1A with the hypophosphorylated form of pRb and pRb-like proteins disrupts the pocket proteins-E2F complexes and enhances the E2F-dependent transcription (Ghosh and Harter, 2003) . The ultimate result of this interaction is that the cell cycle control, normally exerted by G1 cyclins-cyclindependent kinases (CDKs)-cyclin-dependent kinase inhibitors (CDKIs) through the regulation of pRb and pRb-like proteins phosphorylation, is bypassed. As a consequence of pRb displacement, E2F activates the transcription of a number of genes required to drive the cell into S phase and to induce DNA synthesis, including Cyclin A, Cyclin E and CDK2 (Stevaux and Dyson, 2002) .
The activation of the E2F-dependent transcription may also explain the E1A activity against cellular senescence, induced by different stresses and telomere shortening (Ben Porath and Weinberg, 2004; Ben Porath and Weinberg, 2005) . This condition is generally mediated by an increase of the expression of the CDK inhibitors p16
INK4A and p21
CIP1
, which in turn induce the hypophosphorylation and the activation of pRb and pRb-like proteins, thus blocking the E2F transcriptional targets. These targets include the majority of the genes necessary for the G1-S progression.
Another consequence of E2F activation is the transcription of the MDM2 inhibitor p14/p19 ARF , leading to p53 accumulation and to the consequent induction of cell apoptosis (De Stanchina et al., 1998; Berk, 2005) .
Early-region 1A may affect the activity of the pocket proteins also indirectly, altering the function of different cellular mediators. E1A CR1 and N-terminal region bind to p300 (Stein et al., 1990) and CBP (Arany et al., 1995) , multifunctional proteins, interacting with a number of transcriptional factors and endowed with histone acetyltransferase (HAT) activity (Iyer et al., 2004) . The E1A binding alters the activity of these proteins (Frisch and Mymryk, 2002) with effects also on the expression or function of the pocket proteins. In differentiating mouse myoblasts, E1A abrogates the induction of the expression of RB1 by a mechanism that is p300/CBP dependent (Martelli et al., 1994; Magenta et al., 2003) .
Other effects of E1A on the pocket proteins are mediated by the downregulation of the CDK inhibitor p21
, which in turn controls the phosphorylation level of target proteins such pRb. Binding of p300/CBP by E1A inhibits the transcription of the p21
induced by DNA damage (Steegenga et al., 1996; Somasundaram and el-Deiry, 1997) , transforming growth factor-b (TGF-b) (Datto et al., 1997) , keratinocytes and myoblasts terminal differentiation (Missero et al., 1995; Cenciarelli et al., 1999) . In the cases above mentioned, the transcription of p21 CIP1/WAF1 depends either on p53 (Vogelstein et al., 2000) or on differentiation-specific factors like MyoD (Cenciarelli et al., 1999), RB family proteins and small DNA virus oncoproteins A Felsani et al and p300/CBP is the transcriptional coactivator both of p53 (Avantaggiati et al., 1997; Lill et al., 1997) and MyoD (Eckner et al., 1996; Yuan et al., 1996) . The interaction of E1A N-terminal region with p400, a member of SWI2/SNF2 chromatin remodeling complex (Fuchs et al., 2001) , may also deregulate the p53-p21 CIP1/WAF1 pathway, leading to a downregulation of p21 CIP1/WAF1 (Chan et al., 2005) . It has also been reported that E1A directly interacts and consequently inactivates the CKI p21 CIP1/WAF1 (Mal et al., 2000) and p27
KIP1 (Mal et al., 1996) , releasing their inhibition of Cyclin-CDK2 complexes and allowing pRb phosphorylation.
Another post-translational modification of pRb is its acetylation mainly in the C-terminal region, at lysine residues 873/874. pRb is acetylated by the HAT activity of p300 and P/CAF. There is evidence that pRb undergoes acetylation upon myogenic differentiation . The acetylation of pRb enhances its interaction with MDM2 and reduces the efficiency of pRb phosphorylation by CDKs. Early-region 1A stimulates pRb acetylation by recruiting pRb in a ternary complex with p300 (Chan et al., 2001) . The biological significance of pRb acetylation and of the role of E1A in its stimulation, however, remains unclear.
Human Papillomavirus E7
Human papillomavirus generally infects tissues of epithelial origin and is unquestionably linked to human cancer (zur Hausen, 2002) . At present, more than 150 different HPV genotypes have been isolated and grouped roughly into mucosal (a) or skin (b) genotypes, according to their preferred target tissue (De Villiers et al., 2004; Munger et al., 2004) . Productive HPV infection has long been known to cause benign squamous hyperplasias, also known as warts. A large group of HPV types have been associated with carcinomas of the ano-genital tract -particularly cancer of the uterine cervix -with a subset of head and neck squamous cell carcinomas (Kreimer et al., 2005) , and also with cutaneous malignancies (non-melanoma skin cancers) (Pfister, 2003) .
Based on the pathology of the lesions they cause, HPV types are subdivided into 'low-risk' HPVs, which cause benign tumors and 'high-risk' HPVs, which cause lesions that have a propensity for carcinogenic progression. High-risk HPV-16 and -18 have been identified as causative agents of at least 90% of cancers of the cervix and are also linked to more than 50% of other anogenital cancers (zur Hausen, 1996) . All these tumors, however, are usually detected after several years of latency from the diagnosis of HPV infection. Tumorigenic progression of high-risk HPV-associated lesions is almost always accompanied by the physical integration of the viral genome into a host chromosome (zur Hausen, 1996; zur Hausen, 2000) . The viral E6 and E7 genes are the only ones generally retained and consistently expressed by the host cell, suggesting a key role for the respective proteins in the induction of malignant transformation (zur Hausen, 1996; zur Hausen, 2002; Munoz et al., 2003) . Indeed, their oncogenic activities have been documented extensively in tissue cultures and in transgenic mouse model systems (Arbeit et al., 1996; McCance et al., 1988; Hawley-Nelson et al., 1989; Munger et al., 1989a) . These oncoproteins play an important role in the viral life cycle by subverting the tight link between cellular differentiation and proliferation in normal epithelium, thus allowing the virus to replicate in cells that would have normally withdrawn from the cell division cycle and that are committed to terminal differentiation.
The E7 molecule from high-risk HPV strains encompasses three functional regions: CR1 and CR2 in the N-terminal moiety, and a large C-terminal zincfinger domain. While CR1 and CR2 share structural and functional homologies with the corresponding Adenovirus E1A and Polyomavirus large T antigen regions, the zinc-finger domain appears unique and does not have a homologous in the E1A or in the large T antigen molecules. In particular, HPV E7 CR2 region shares a small block of amino-acid sequence similarity with Adenovirus E1A and Polyomavirus large T antigens (Phelps et al., 1988; Vousden and Jat, 1989) (Figure 1 ). This sequence contains the LxCxE motif, the canonical binding site for pRb and the related pocket proteins p107 and pRb2/p130 which negatively regulate progression from G0 through G1 and into the S phase of cell cycle (Dyson et al., 1989a, b; Davies et al., 1993; Hu et al., 1995) . Like E1A and large T antigen, HPV 16 E7 binds to the RB family members and, analogously to the CDK-mediated phosphorylation, causes the release of active E2F transcription factors and the transactivation of E2F-responsive genes necessary for the cell cycle progression (Ikeda and Nevins, 1993; Tommasino and Crawford, 1995; Mu¨ller and Helin, 2000) . Several lines of evidence suggest that the ability of E7 to interfere with the pRb/E2F complex formation is required for viral replication (Flores et al., 2000) , but the E7/RB family proteins interaction is not sufficient for cellular transformation (Caldeira et al., 2000; Munger et al., 2001; Scheffner and Whitaker, 2003) . E7 proteins from lowrisk HPV strains do not show oncogenic potential in cell culture transformation assays and bind to pRb at a lower efficiency than the high-risk HPV E7 Gage et al., 1990) , but retain the ability to disrupt pRb/E2F complexes (Ciccolini et al., 1994; Munger et al., 2001 ). In addition, several non-transforming HPV-16 E7 mutants maintain the ability to interact with pRb and efficiently activate transcription of E2F-responsive promoters (Banks et al., 1990; Brokaw et al., 1994) .
The HPV-16 E7 zinc-finger motif (aa 60-98) is linked to the HPV ability to immortalize the infected cell (Jewers et al., 1992) . If this region is involved or not in the binding of E7 with the RB family proteins is controversial (McIntyre et al., 1993; Patrick et al., 1994) , but it is definitely involved in the interference with several important cellular factors, as the AP1 transcriptional machinery, HDAC-1, pCAF and BRCA1 (Antinore et al., 1996; Brehm et al., 1999; Park et al., 2000; Avvakumov et al., 2003; Zhang et al., 2005) .
A further mechanism proposed to explain how E7 functionally antagonizes pRb has been suggested by the observation that the interaction with high-risk HPV E7 proteins results in ubiquitin-mediated degradation of pRb family proteins (Boyer et al., 1996; Berezutskaya et al., 1997; Jones et al., 1997; Helt and Galloway, 2001 ). In addition to the LxCxE domain, sequences within the amino-terminal CR1 homology domain of high-risk HPV E7 are necessary for the destabilization of the pocket proteins (Helt and Galloway, 2001 ). It appears that pRb proteolytic degradation, but not pRb binding, is necessary for full inactivation of pRb functions and for oncogenic activity of high-risk E7 .
Recruitment of the 26S proteasome activity by HPV-16 E7, but not by HPV-6 E7, (Demers et al., 1994) , may involve the specific interaction with the S4-ATPase subunit (Berezutskaya et al., 1997) . This proposed mechanism of proteolytic degradation would assure an efficiently inactivation of the growth inhibitory function of pRb even with low intracellular E7 concentrations. In fact, E7, owing to its low level of expression and to its short half-life, which is less than 2 h (Reinstein et al., 2000) , can result stoichiometrically disadvantaged towards the pRb molecule, so the combined strategy of the induction of an enzymatic reaction in order to disrupt pRb can be remarkably more efficient in releasing the blockade of the cell cycle. Interestingly, binding of E7 to pRb is necessary but not sufficient for pRb degradation; indeed, E7 proteins encoded by low-risk HPVs, as well as Adenovirus E1A and Polyomavirus large T antigens, bind to pRb with high affinity without inducing its destabilization (Schmitt et al., 1994; Helt and Galloway, 2003) . Furthermore, the same regions of E7 necessary for pRb destabilization are effective in downmodulating p107 and pRb2/p130 (Helt and Galloway, 2001) .
Polyomavirus large T-antigen
Twelve members of the Polyomaviridae, a family of small DNA viruses, have been so far identified (Cole, 1996) , but the ones potentially relevant for cancer epidemiology in humans are essentially three: SV40, JCV and BKV. The natural host of SV40 is the monkey Macacus Rhesus, but even if SV40 usually does not infect humans, accidental injection of SV40 has been reported in people taking the injected form of the polio vaccine between the years 1955 and 1963 (Rizzo et al., 1999; Jasani et al., 2001; Barbanti-Brodano et al., 2004; Dang-Tan et al., 2004) . On the other hand, long-term epidemiology studies have failed to detect an increased cancer risk in those individuals likely to have been exposed to the virus mainly by SV40-contaminated polio vaccines (Mortimer et al., 1981; Strickler et al., 1998) .
The interest on the potential role of SV40 in human cancer has been recently renewed because of the possible involvement of this virus in human pleural mesothelioma (Carbone et al., 1994; Carbone, 2000) , a rare but fatal tumor already epidemiologically linked to asbestos exposure (Mossman and Gee, 1989; Tweedale, 2002; Boffetta, 2004) . A report by the Institute of Medicine (IOM) concludes that the evidence is insufficient to prove or disprove the theory that exposure to SV40-contaminated poliovirus vaccine resulted in cancer in humans (http://www.iom.edu/iom/iomhome.nsf/pages/ Sv40+Report?OpenDocument), so the issue remains open (Carbone et al., 1997; Klein et al., 2002; BarbantiBrodano et al., 2004; Engels, 2005) . Conversely, although the presence of SV40 in humans can still be considered just incidental, JCV is estimated to infect up to 90% of the humans. This virus is the pathogenetic agent of the progressive multifocal leukoencephalopathy (PML), a relatively rare neurological demyelinating disorder occurring essentially in immunosuppressed or immunodeficient people (Berger and Concha, 1995) . The occurrence of a statistically significant increase of CNS and non-CNS tumor incidence, as well as the presence of viral DNA in those patients, confers to JCV the status of tumor virus Reiss and Khalili, 2003) . Similarly to JCV, BKV is widely spread among the human population and its sequences and T antigen are detected in several types of human neoplasms (Tognon et al., 2003) .
As for Adenovirus and HPV, SV40, JCV and BKV code for early proteins, which perform an essential role in the first post-infection period. Such factors are the Polyomavirus tumor antigens (T-antigens), essentially devoted to the activation of the machinery committed to cell replication inside the resting infected cell. In this way, cellular factors indispensable for DNA replication become immediately available in order to replicate efficiently the genome of the infecting virus. Differential splicing of these RNAs generates several transcripts and protein products, the most abundant ones being the oncoproteins named large and small T-antigens (Cole, 1996) . SV40, JCV and BKV large T-antigens share a >70% amino-acid sequence homology and are depicted in Figure 1 . All these three large T-antigens possess a J domain, the homologous of a region conserved among all cellular DnaJ/Hsp40 molecular chaperones, essential for chaperone activity and for the interaction with the DnaK homolog Hsp70/Hsc70 chaperone machinery Kelley and Georgopoulos, 1997; Srinivasan et al., 1997) . Simian virus 40, JCV and BKV large T-antigen (LT-Ag) also possess the LxCxE motif, through which they physically interact with all the members of the RB family proteins (Dahiya et al., 2000) , which in turn bind to the viral factors through their 'pocket' domain (Paggi et al., 1996; Helt and Galloway, 2003) . Binding of LT-Ag, as well as E1A or E7, to the pocket region of the RB proteins results in the physical displacement of physiologically interacting partners, apart from the presence or the absence of a LxCxE motif (e.g. HDAC-1 and -2 or the E2F family, respectively). Once again, these viral oncoproteins are thus able to disrupt the regulatory properties of the RB family proteins, thereby forcing irreversibly the cell to an anticipated progression to the S phase of the cell cycle and eventually to an unscheduled mitosis.
In spite of their structural similarities, these oncoproteins display different efficacy in inhibiting the function of any single member of the RB family proteins, which, in turn, show different sensitivity to the effect of these viral oncoproteins. Thus, for sake of clarity, these will be considered individually.
Simian 40 large T-antigen Simian 40 large T-Ag is considered the most powerful Polyomavirus LT-Ag in eliciting cell transformation (Wang et al., 2004) . It is composed of 708 amino acids. The N-terminal portion contains three important functional domains, namely CR1, J-domain and CR2 (Powell et al., 1999) . The CR1, comprised within the J-domain (residues 1-82), is necessary for SV40 LT-Agmediated transformation capabilities (Srinivasan et al., 1997) ; CR2 physically contains the LxCxE motif (residues 103-107) and is thus responsible for the binding with pRb, p107 and pRb2/p130 (Zalvide and DeCaprio, 1995; Kim et al., 2001) . From a functional point of view, while the LxCxE motif serves to the physical docking of SV40 LT-Ag to the RB family proteins, the J-domain results indispensable for the inactivation of the ability of each member of the pRb family to induce G1 arrest (Zalvide et al., 1998) .
Studies in mouse pRb-defective embryo fibroblasts demonstrated that pRb2/p130 and p107 may be crucial targets for SV40 LT-Ag (Christensen and Imperiale, 1995; Zalvide and DeCaprio, 1995) , which is able to induce specifically dephosphorylation of both pRb2/ p130 and p107 (Stubdal et al., 1996; Lin and DeCaprio, 2003) and proteolytic degradation of pRb2/p130 without affecting pRb or p107 . Indeed, these and other specific and selective features of SV40 LT-Ag J domain towards pRb (Kim et al., 2001) , p107 or pRb2/p130 (Knudsen and Wang, 1998) indirectly support the hypothesis of different roles of these pocket proteins in selected cellular processes.
JC virus large T-antigen
In spite of the high incidence of JCV infection in the humans, the link between this virus and human cancer is still not fully demonstrated. JC virus oncogenicity is doubtlessly evident in murine models, especially in the development of tumors arising from neuro-ectodermal cells, such as medulloblastoma and astrocytoma, but also from non-neural tissues, for example, colorectal carcinoma. Most of the JCV carcinogenic potential is attributed to JCV LT-Ag that, as the cognate SV40 LTAg, is able to interact and neutralize key oncosuppressor proteins, as the RB family factors and p53 (Bollag et al., 1989; Haggerty et al., 1989) and is necessary for viral replication and for cell transformation (Helt and Galloway, 2003) . JC virus LT-Ag is composed of 688 amino acids and is structured rather similarly to the SV40 LT-Ag oncoprotein (Figure 1 ). It possesses an LxCxE motif in the CR2 and a functional J domain, although less efficient than the one of SV40 LT-Ag (Sullivan et al., 2000) . Thus, JCV LT-Ag is likely to inactivate the RB family proteins via the same mechanisms described for its SV40 homolog, that is, via direct binding and chaperone-dependent properties. In JCV, an important functional role is also sustained by truncated JCV LT-Ag forms, generated by alternative splicing products which contain the LxCxE motif and the J domain (Trowbridge and Frisque, 1995) . Indeed, these alternatively spliced JCV LT-Ags are all able to bind to and neutralize the RB family proteins, even if with different affinity. The majority of p107 and pRb2/ p130 is found complexed with these JCV LT-Ag forms in a manner not dependent upon their phosphorylation status, while pRb is found bound essentially in its hypophosphorylated form. Moreover, in JCV-transformed cells, expression level and phosphorylation of the three RB family proteins results rather changed; in fact, pRb2/p130 level is reduced and appears essentially as an underphosphorylated protein, whereas pRb and p107 appear overexpressed, pRb being mainly present in its hyperphosphorylated form (Bollag et al., 2000) .
BK virus large T-Ag
To consider BKV LT-Ag in a separate paragraph may appear somewhat redundant owing to the many structural and functional homologies with JCV LT-Ag, but it is deserved by the high frequence of BKV infection in humans. Indeed, similarly to JCV, BKV infects a large percentage of individuals and becomes clinically evident mainly in immunodeficient or immunosuppressed patients (Wang et al., 2004) . Equally, BKV DNA has been detected in human tumors, not only of the CNS but also of the pancreas and the urinary tract (Harris et al., 1998a; Croul et al., 2003; Fioriti et al., 2005) . BK virus LT-Ag is composed of 695 amino acids and is structurally similar to SV40 and JCV LT-Ag (Figure 1) . Again, functional similarities regard its ability to physically interact with the RB family of pocket proteins, even if the experimental conditions employed to demonstrate such interactions appear somewhat forced, when compared to those applied for the cognate SV40 and JCV oncoproteins (Harris et al., 1996) . In the intact cell, low levels of BKV LT-Ag, even if undetectable in their binding with the RB proteins, induce a serum-independent phenotype and downregulation of all the three RB family proteins as well as the release of transcriptionally functional E2F, fully dependent upon the presence of intact LxCxE motif and J domain in the BKV LT-Ag molecule. This suggests a different, but not well characterized yet, mechanism regulating the BKV LT-Ag-mediated E2F release (Harris et al., 1998b) .
Conclusions
Unquestionably, the RB family of proteins are master regulators in multiple essential cellular functions, and are known to perform within the cell common functions -well explained by their extensive structural homology, for example, the pocket domain -as well as specific functions in which the three family members cannot be considered redundant (Mulligan and Jacks, 1998; Classon and Dyson, 2001; Paggi and Giordano, 2001) . Clearly, from these notions, we understand the propensity of the oncoviruses to consider the RB family as a privileged target. To this end, the viral oncoproteins E1A, E7 and LT-Ag have been comparably engineered by the respective viruses in order to perform analogous tasks within the infected/transformed host cell, and among these tasks, the most investigated, if not the most important, is the impairment of the functions of the RB family factors. In spite of the fact that these viral oncoproteins share significantly homologous functional domains, for example, CR2 and the LxCxE motif therein, these appear comprised in considerably dissimilar molecular contexts (Figure 1) . It looks as if these small DNA oncoviruses have developed distinct molecular structures through different evolutive pathways, addressed to perform several overlapping tasks. Anyway, the interplay of the RB family of proteins with these viral oncoproteins can assume a multifaceted scenario whose complete analytical disclosure would not improve substantially the notion of the influence of these viral factors in the cell homeostasis. However, interestingly, specific and selective behaviors of these oncoproteins in interfering with the RB family members, for example, the specificity of the binding of SV40 LTAg J domain towards pRb, p107 or pRb2/p130 (Knudsen and Wang, 1998; Kim et al., 2001) , could indirectly reinforce the hypothesis that these three factors are devoted to perform also non-overlapping functions within the cell.
